Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene.
paper
Cited
Public
Unavailable
- Authors
- Schwartz, Charles E; May, Melanie M; Carpenter, Nancy J; Rogers, R Curtis; Martin, Judith; Bialer, Martin G; Ward, Jewell; Sanabria, Javier; Marsa, Silvana; Lewis, James A; Echeverri, Roberto; Lubs, Herbert A; Voeller, Kytja; Simensen, Richard J; Stevenson, Roger E
- Year
- 2005
- Journal
- American journal of human genetics
- PMID
- 15889350
- DOI
- 10.1086/431313
- PMCID
- PMC1226193
Allan-Herndon-Dudley syndrome was among the first of the X-linked mental retardation syndromes to be described (in 1944) and among the first to be regionally mapped on the X chromosome (in 1990). Six large families with the syndrome have been identified, and linkage studies have placed the gene locus in Xq13.2. Mutations in the monocarboxylate transporter 8 gene (MCT8) have been found in each of the six families. One essential function of the protein encoded by this gene appears to be the transport of triiodothyronine into neurons. Abnormal transporter function is reflected in elevated free triiodothyronine and lowered free thyroxine levels in the blood. Infancy and childhood in the Allan-Herndon-Dudley syndrome are marked by hypotonia, weakness, reduced muscle mass, and delay of developmental milestones. Facial manifestations are not distinctive, but the face tends to be elongated with bifrontal narrowing, and the ears are often simply formed or cupped. Some patients have myopathic facies. Generalized weakness is manifested by excessive drooling, forward positioning of the head and neck, failure to ambulate independently, or ataxia in those who do ambulate. Speech is dysarthric or absent altogether. Hypotonia gives way in adult life to spasticity. The hands exhibit dystonic and athetoid posturing and fisting. Cognitive development is severely impaired. No major malformations occur, intrauterine growth is not impaired, and head circumference and genital development are usually normal. Behavior tends to be passive, with little evidence of aggressive or disruptive behavior. Although clinical signs of thyroid dysfunction are usually absent in affected males, the disturbances in blood levels of thyroid hormones suggest the possibility of systematic detection through screening of high-risk populations.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. | 2010 | 20844286 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Strategies for blood-brain barrier rejuvenation and repair. | Searson PC et al. | β | 2026 | β |
| Characterization of thyroid hormone transport in a human choroid plexus papilloma cell line (HIBCPP) as an in vitro blood-cerebrospinal fluid barrier model. | Wagenaars F et al. | β | 2025 | β |
| Cryo-EM structure of the human monocarboxylate transporter 10. | BΓ₯genholm V et al. | β | 2025 | β |
| Differentiation versus dysfunction: thyroid hormone, deiodinases and retinal photoreceptors. | Ng L et al. | β | 2025 | β |
| Inactivation of Thyroid Hormone Transporters Mct8/Oatp1c1 in Mouse Brain Endothelial Cells Causes Region-Specific Alterations in Central Thyroid Hormone Signaling. | Alevyzaki A et al. | β | 2025 | β |
| Increased seizure susceptibility in thyroid hormone transporter Mct8/Oatp1c1 knockout mice is associated with altered neurotransmitter systems development. | Alcaide Martin A et al. | β | 2025 | β |
| MCT8 Deficiency in Females. | Groeneweg S et al. | β | 2025 | β |
| Novel <i>SLC16A2</i> Frameshift Mutation as a Cause of Allan-Herndon-Dudley Syndrome and its Implications for Carrier Screening. | Lin P et al. | β | 2025 | β |
| Pathogenic MCT8V235L creates a steric clash that is alleviated by a compensating mutation of MCT8F285A. | Sonntag N et al. | β | 2025 | β |
| Phenylbutyrate Treatment in a Boy With MCT8 Deficiency: Improvement of Thyroid Function Tests and Possible Hepatotoxicity. | Schreiner F et al. | β | 2025 | β |
| Sciatic nerve analysis in thyroid hormone transporters Mct8 and Oatp1c1 knockout mice. | Mayerl S et al. | β | 2025 | β |
| Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1. | Ge Y et al. | β | 2025 | β |
| A Highly Selective Fluorescent Probe for Monitoring the Thyroid Hormone Transporter Activity in Mammalian Cells. | Giri D et al. | β | 2024 | β |
| A Novel Mutation Diagnosing in Allan-Herndon-Dudley's Syndrome. | Ipek R et al. | β | 2024 | β |
| Clinical and genetic characteristics of patients with monocarboxylate transporter-8 deficiency: a multicentre retrospective study. | Γelik N et al. | β | 2024 | β |
| Combined Levothyroxine and Propylthiouracil Treatment in Children with Monocarboxylate Transporter 8 Deficiency: A Multicenter Case Series of 12 Patients. | Weiss RE et al. | β | 2024 | β |
| Cone photoreceptor differentiation regulated by thyroid hormone transporter MCT8 in the retinal pigment epithelium. | Liu Y et al. | β | 2024 | β |
| Diagnosis and Therapy in MCT8 Deficiency: Ongoing Challenges | Freund MET et al. | β | 2024 | β |
| Gene polymorphisms and thyroid hormone signaling: implication for the treatment of hypothyroidism. | Penna GC et al. | β | 2024 | β |
| Identification of a novel nonsense SLC16A2 gene mutation in an infant with severe neurologic phenotype: A case report. | Peng W et al. | β | 2024 | β |
| Identification of Human TRIAC Transmembrane Transporters. | Becker PC et al. | β | 2024 | β |
| Identification of Iodotyrosines as Novel Substrates for the Thyroid Hormone Transporter MCT8. | Groeneweg S et al. | β | 2024 | β |
| Mapping Thyroid Hormone Action in the Human Brain. | Salas-Lucia F | β | 2024 | β |
| Perinatal exposure to environmental chemicals that disrupt thyroid function can perturb testis development. | Draskau MK et al. | β | 2024 | β |
| Screening for endocrine disrupting chemicals inhibiting monocarboxylate 8 (MCT8) transporter facilitated thyroid hormone transport using a modified nonradioactive assay. | Wagenaars F et al. | β | 2024 | β |
| Thyroid hormone biosynthesis and its role in brain development and maintenance. | de Souza JS | β | 2024 | β |
| Toward a treatment for thyroid hormone transporter MCT8 deficiency - achievements and challenges. | Markova B et al. | β | 2024 | β |
| Two novel in vitro assays to screen chemicals for their capacity to inhibit thyroid hormone transmembrane transporter proteins OATP1C1 and OAT4. | Wagenaars F et al. | β | 2024 | β |
| Distribution of Monocarboxylate Transporters in Brain and Choroid Plexus Epithelium. | Ueno M et al. | β | 2023 | β |
| Establishing Patient-Centered Outcomes for MCT8 Deficiency: Stakeholder Engagement and Systematic Literature Review. | Wilpert NM et al. | β | 2023 | β |
| Parent Perspectives on Complex Needs in Patients With MCT8 Deficiency: An International, Prospective, Registry Study. | van Geest FS et al. | β | 2023 | β |
| Proteome Analysis of Thyroid Hormone Transporter Mct8/Oatp1c1-Deficient Mice Reveals Novel Dysregulated Target Molecules Involved in Locomotor Function. | Siemes D et al. | β | 2023 | β |
| Repetitive Sleep Starts in Allan-Herndon-Dudley Syndrome. | Solazzi R et al. | β | 2023 | β |
| Role and Clinical Significance of Monocarboxylate Transporter 8 (MCT8) During Pregnancy. | Thomas J et al. | β | 2023 | β |
| Thyroid hormone action during GABAergic neuron maturation: The quest for mechanisms. | Richard S et al. | β | 2023 | β |
| Thyroid hormone transporter Mct8/Oatp1c1 deficiency compromises proper oligodendrocyte maturation in the mouse CNS. | Mayerl S et al. | β | 2023 | β |
| Triac Treatment Prevents Neurodevelopmental and Locomotor Impairments in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice. | Chen J et al. | β | 2023 | β |
| AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency. | Liao XH et al. | β | 2022 | β |
| Allan-Herndon-Dudley Syndrome: A Novel Pathogenic Variant of the SLC16A2 gene. | Beheshti R et al. | β | 2022 | β |
| Allan-Herndon-Dudley syndrome in a female patient and related mechanisms. | Olivati C et al. | β | 2022 | β |
| A nationwide survey of monocarboxylate transporter 8 deficiency in Japan: Its incidence, clinical course, MRI and laboratory findings. | Kubota M et al. | β | 2022 | β |
| A novel frameshift mutation in Allan-Herndon-Dudley syndrome. | Liu Z et al. | β | 2022 | β |
| A novel variant in SLC16A2 associated with typical Allan-Herndon-Dudley syndrome: a case report. | Chen X et al. | β | 2022 | β |
| Development and validation of an LC-MS/MS methodology for the quantification of thyroid hormones in dko MCT8/OATP1C1 mouse brain. | De Angelis M et al. | β | 2022 | β |
| Distinct Actions of the Thyroid Hormone Transporters Mct8 and Oatp1c1 in Murine Adult Hippocampal Neurogenesis. | Mayerl S et al. | β | 2022 | β |
| Ganglioglioma with novel molecular features presenting in a child with Allan-Herndon-Dudley syndrome. | Adams JW et al. | β | 2022 | β |
| Gene therapy targeting the blood-brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency. | Sundaram SM et al. | β | 2022 | β |
| Genomic variants reducing expression of two endocytic receptors in 46,XY differences of sex development. | Marko HL et al. | β | 2022 | β |
| IGSF1 Deficiency Leads to Reduced TSH Production Independent of Alterations in Thyroid Hormone Action in Male Mice. | BrΓ»lΓ© E et al. | β | 2022 | β |
| Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study. | van Geest FS et al. | β | 2022 | β |
| Mathematical modeling and simulation of thyroid homeostasis: Implications for the Allan-Herndon-Dudley syndrome. | Wolff TM et al. | β | 2022 | β |
| Mathematical Modeling of Thyroid Homeostasis: Implications for the Allan-Herndon-Dudley Syndrome | Wolff TM et al. | β | 2022 | β |
| Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update. | Lange LM et al. | β | 2022 | β |
| The Thyroid Hormone Transporter MCT10 Is a Novel Regulator of Trabecular Bone Mass and Bone Turnover in Male Mice. | Lademann F et al. | β | 2022 | β |
| Thyroid Hormone Transporter Deficiency in Mice Impacts Multiple Stages of GABAergic Interneuron Development. | Mayerl S et al. | β | 2022 | β |
| Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad. | Morte B et al. | β | 2021 | β |
| Choking and Cyanotic Episodes in a 3-month-old Male. | Paris G et al. | β | 2021 | β |
| Clinical and Functional Consequences of C-Terminal Variants in MCT8: A Case Series. | van Geest FS et al. | β | 2021 | β |
| Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications. | SchΓ€fer AM et al. | β | 2021 | β |
| Genetics of primary congenital hypothyroidism-a review. | Kostopoulou E et al. | β | 2021 | β |
| Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development. | van Geest FS et al. | β | 2021 | β |
| Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment. | van Geest FS et al. | β | 2021 | β |
| Oligodendrocyte progenitor cell maturation is dependent on dual function of MCT8 in the transport of thyroid hormone across brain barriers and the plasma membrane. | Vatine GD et al. | β | 2021 | β |
| Prenatal Treatment of Thyroid Hormone Cell Membrane Transport Defect Caused by <i>MCT8</i> Gene Mutation. | Refetoff S et al. | β | 2021 | β |
| Regional Difference in Myelination in Monocarboxylate Transporter 8 Deficiency: Case Reports and Literature Review of Cases in Japan. | Iwayama H et al. | β | 2021 | β |
| The making of a potent L-lactate transport inhibitor. | Bosshart PD et al. | β | 2021 | β |
| The role of SLC transporters for brain health and disease. | Nguyen YTK et al. | β | 2021 | β |
| The Role of Thyroid Function Tests in Diagnosing Allan-herndon-dudley Syndrome Revisited: A Novel Iran-based Mutation. | Noorian S et al. | β | 2021 | β |
| Thyroid hormone, gene expression, and Central Nervous System: Where we are. | Giannocco G et al. | β | 2021 | β |
| Thyroid Hormone Transporter Defect: Allan Herndon Dudley Syndrome, Masquerading as Dyskinetic Cerebral Palsy. | Gowda VK et al. | β | 2021 | β |
| Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment Strategies. | Krude H et al. | β | 2020 | β |
| CRISRP/Cas9-mediated knockout of Mct8 reveals a functional involvement of Mct8 in testis and sperm development in a rat. | Bae HS et al. | β | 2020 | β |
| Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study. | Groeneweg S et al. | β | 2020 | β |
| Hippocampal Neurogenesis Requires Cell-Autonomous Thyroid Hormone Signaling. | Mayerl S et al. | β | 2020 | β |
| Intranasal delivery of Thyroid hormones in MCT8 deficiency. | Grijota-MartΓnez C et al. | β | 2020 | β |
| Lack of the Thyroid Hormone Transporter Mct8 in Osteoblast and Osteoclast Progenitors Increases Trabecular Bone in Male Mice. | Lademann F et al. | β | 2020 | β |
| Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination? | Vancamp P et al. | β | 2020 | β |
| Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease. | Felmlee MA et al. | β | 2020 | β |
| Sorting Variants of Unknown Significance Identified by Whole Exome Sequencing: Genetic and Laboratory Investigations of Two Novel <i>MCT8</i> Variants. | Fu J et al. | β | 2020 | β |
| Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression. | Wilpert NM et al. | β | 2020 | β |
| The placenta in fetal thyroid hormone delivery: from normal physiology to adaptive mechanisms in complicated pregnancies. | Eerdekens A et al. | β | 2020 | β |
| The Protein Translocation Defect of MCT8<sup>L291R</sup> Is Rescued by Sodium Phenylbutyrate. | Braun D et al. | β | 2020 | β |
| Thyroid Hormone Transporters. | Groeneweg S et al. | β | 2020 | β |
| Tissue-Specific Function of Thyroid Hormone Transporters: New Insights from Mouse Models. | Salveridou E et al. | β | 2020 | β |
| Adult Mice Lacking Mct8 and Dio2 Proteins Present Alterations in Peripheral Thyroid Hormone Levels and Severe Brain and Motor Skill Impairments. | BΓ‘rez-LΓ³pez S et al. | β | 2019 | β |
| Adult onset of type 3 deiodinase deficiency in mice alters brain gene expression and increases locomotor activity. | Stohn JP et al. | β | 2019 | β |
| Characterization and Proteomic-Transcriptomic Investigation of Monocarboxylate Transporter 6 Knockout Mice: Evidence of a Potential Role in Glucose and Lipid Metabolism. | Jones RS et al. | β | 2019 | β |
| Combination Thyroid Hormone Replacement; Knowns and Unknowns. | Taylor PN et al. | β | 2019 | β |
| Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations. | Remerand G et al. | β | 2019 | β |
| Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients. | Islam MS et al. | β | 2019 | β |
| Intracerebroventricular administration of the thyroid hormone analog TRIAC increases its brain content in the absence of MCT8. | BΓ‘rez-LΓ³pez S et al. | β | 2019 | β |
| Modeling the Biochemical Phenotype of MCT8 Mutations In Vitro: Resolving a Troubling Inconsistency. | Braun D et al. | β | 2019 | β |
| Novel mutations in SLC16A2 associated with a less severe phenotype of MCT8 deficiency. | Masnada S et al. | β | 2019 | β |
| Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions. | Kim MJ et al. | β | 2019 | β |
| Paroxysmal Movement Disorders: Recent Advances. | Xu Z et al. | β | 2019 | β |
| Thyroid hormone availability in the human fetal brain: novel entry pathways and role of radial glia. | LΓ³pez-EspΓndola D et al. | β | 2019 | β |
| Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back. | Rurale G et al. | β | 2019 | β |
| Thyroid Hormones in the Brain and Their Impact in Recovery Mechanisms After Stroke. | Talhada D et al. | β | 2019 | β |
| Deafness and loss of cochlear hair cells in the absence of thyroid hormone transporters Slc16a2 (Mct8) and Slc16a10 (Mct10). | Sharlin DS et al. | β | 2018 | β |
| Effects of Chemical Chaperones on Thyroid Hormone Transport by MCT8 Mutants in Patient-Derived Fibroblasts. | Groeneweg S et al. | β | 2018 | β |
| From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development. | Vancamp P et al. | β | 2018 | β |
| Intermittent Esotropia in 4 Patients With Allan-Herndon-Dudley Syndrome. | Swiston CJ et al. | β | 2018 | β |
| Neurogenetics of Pelizaeus-Merzbacher disease. | OsΓ³rio MJ et al. | β | 2018 | β |
| Regulation of T3 Availability in the Developing Brain: The Mouse Genetics Contribution. | Richard S et al. | β | 2018 | β |
| Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain. | BΓ‘rez-LΓ³pez S et al. | β | 2018 | β |
| Thyroid Hormone Transport and Transporters. | Braun D et al. | β | 2018 | β |
| Thyroid Hormone Transporters MCT8 and OATP1C1 Control Skeletal Muscle Regeneration. | Mayerl S et al. | β | 2018 | β |
| An Essential Physiological Role for MCT8 in Bone in Male Mice. | Leitch VD et al. | β | 2017 | β |
| Blocked, delayed, or obstructed: What causes poor white matter development in intrauterine growth restricted infants? | Tolcos M et al. | β | 2017 | β |
| Can Thyroid Hormone Analogues Be Used to Overcome Hypomyelination and Demyelination of the Central Nervous System? | Cullen CL et al. | β | 2017 | β |
| Deficiency of the Thyroid Hormone Transporter Monocarboxylate Transporter 8 in Neural Progenitors Impairs Cellular Processes Crucial for Early Corticogenesis. | Vancamp P et al. | β | 2017 | β |
| Disorder of thyroid hormone transport into the tissues. | Groeneweg S et al. | β | 2017 | β |
| Dissecting the role of regulators of thyroid hormone availability in early brain development: Merits and potential of the chicken embryo model. | Vancamp P et al. | β | 2017 | β |
| Membrane-traversing mechanism of thyroid hormone transport by monocarboxylate transporter 8. | Protze J et al. | β | 2017 | β |
| Ocular manifestations in the X-linked intellectual disability syndromes. | Couser NL et al. | β | 2017 | β |
| Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination. | Lee JY et al. | β | 2017 | β |
| Adeno Associated Virus 9-Based Gene Therapy Delivers a Functional Monocarboxylate Transporter 8, Improving Thyroid Hormone Availability to the Brain of Mct8-Deficient Mice. | Iwayama H et al. | β | 2016 | β |
| Chemistry and Biology in the Biosynthesis and Action of Thyroid Hormones. | Mondal S et al. | β | 2016 | β |
| Diiodothyropropionic acid (DITPA) cross-reacts with thyroid function assays on different immunoassay platforms. | Leung EK et al. | β | 2016 | β |
| Effect of Triiodothyroacetic Acid Treatment in Mct8 Deficiency: A Word of Caution. | BΓ‘rez-LΓ³pez S et al. | β | 2016 | β |
| Expression of Monocarboxylate Transporter Isoforms in Rat Skeletal Muscle Under Hypoxic Preconditioning and Endurance Training. | Saxena S et al. | β | 2016 | β |
| Few Amino Acid Exchanges Expand the Substrate Spectrum of Monocarboxylate Transporter 10. | Johannes J et al. | β | 2016 | β |
| Inflammation severely alters thyroid hormone signaling in the central nervous system during experimental allergic encephalomyelitis in rat: Direct impact on OPCs differentiation failure. | FernΓ‘ndez M et al. | β | 2016 | β |
| Inherited Xq13.2-q21.31 duplication in a boy with recurrent seizures and pubertal gynecomastia: Clinical, chromosomal and aCGH characterization. | Linhares ND et al. | β | 2016 | β |
| Mct8 and trh co-expression throughout the hypothalamic paraventricular nucleus is modified by dehydration-induced anorexia in rats. | Alvarez-Salas E et al. | β | 2016 | β |
| MCT8 Deficiency in Male Mice Mitigates the Phenotypic Abnormalities Associated With the Absence of a Functional Type 3 Deiodinase. | Stohn JP et al. | β | 2016 | β |
| Mitochondrial Actions of Thyroid Hormone. | Lanni A et al. | β | 2016 | β |
| Monocarboxylate Transporters: Therapeutic Targets and Prognostic Factors in Disease. | Jones RS et al. | β | 2016 | β |
| Novel SLC16A2 mutations in patients with Allan-Herndon-Dudley syndrome. | Shimojima K et al. | β | 2016 | β |
| Three novel mutations of the MCT8 (SLC16A2) gene: individual and temporal variations of endocrinological and radiological features. | Ono E et al. | β | 2016 | β |
| A 7-month-old male with Allan-Herndon-Dudley syndrome and the power of T3. | Langley KG et al. | β | 2015 | β |
| Allan-Herndon-Dudley syndrome with unusual profound sensorineural hearing loss. | Gagliardi L et al. | β | 2015 | β |
| Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting. | Klebe S et al. | β | 2015 | β |
| Comment on "delayed myelination is not a constant feature of Allan-Herndon-Dudley syndrome: report of a new case and review of the literature" by Azzolini S et al. Brain & Development 2014;36:716-720. | Yamamoto T et al. | β | 2015 | β |
| Deletion of exon 1 of the SLC16A2 gene: a common occurrence in patients with Allan-Herndon-Dudley syndrome. | GarcΓa-de Teresa B et al. | β | 2015 | β |
| Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology. | Tesson C et al. | β | 2015 | β |
| Efficient Activation of Pathogenic ΞPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones. | Braun D et al. | β | 2015 | β |
| Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation. | Armour CM et al. | β | 2015 | β |
| Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations. | Fischer J et al. | β | 2015 | β |
| Myelination Delay and Allan-Herndon-Dudley Syndrome Caused by a Novel Mutation in the SLC16A2 Gene. | La Piana R et al. | β | 2015 | β |
| Role of the Thyroid System in Myelination and Neural Connectivity. | CalzΓ L et al. | β | 2015 | β |
| The expanding spectrum of thyroid hormone resistance concerns the entire medical field. | WΓ©meau JL | β | 2015 | β |
| The ratio of serum free triiodothyronine to free thyroxine in children: a retrospective database survey of healthy short individuals and patients with severe thyroid hypoplasia or central hypothyroidism. | Oto Y et al. | β | 2015 | β |
| Thyroid hormone transporters--functions and clinical implications. | Bernal J et al. | β | 2015 | β |
| Cerebral cortex hyperthyroidism of newborn mct8-deficient mice transiently suppressed by lat2 inactivation. | NΓΊΓ±ez B et al. | β | 2014 | β |
| Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation. | Kobayashi S et al. | β | 2014 | β |
| Delayed myelination is not a constant feature of Allan-Herndon-Dudley syndrome: report of a new case and review of the literature. | Azzolini S et al. | β | 2014 | β |
| Expression pattern of thyroid hormone transporters in the postnatal mouse brain. | MΓΌller J et al. | β | 2014 | β |
| Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS. | Ashraf T et al. | β | 2014 | β |
| Genetic disorders of thyroid metabolism and brain development. | Kurian MA et al. | β | 2014 | β |
| Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. | Lo Giudice T et al. | β | 2014 | β |
| Inherited defects in thyroid hormone cell-membrane transport and metabolism. | Fu J et al. | β | 2014 | β |
| Knockdown of monocarboxylate transporter 8 (mct8) disturbs brain development and locomotion in zebrafish. | de Vrieze E et al. | β | 2014 | β |
| MCT8 expression in human fetal cerebral cortex is reduced in severe intrauterine growth restriction. | Chan SY et al. | β | 2014 | β |
| Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination. | LΓ³pez-EspΓndola D et al. | β | 2014 | β |
| Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations. | AnΔ±k A et al. | β | 2014 | β |
| Structure and function of thyroid hormone plasma membrane transporters. | Schweizer U et al. | β | 2014 | β |
| Tissue-specific alterations in thyroid hormone homeostasis in combined Mct10 and Mct8 deficiency. | MΓΌller J et al. | β | 2014 | β |
| Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. | Mayerl S et al. | β | 2014 | β |
| Transport of thyroid hormone in brain. | Wirth EK et al. | β | 2014 | β |
| X-exome sequencing in Finnish families with intellectual disability--four novel mutations and two novel syndromic phenotypes. | Philips AK et al. | β | 2014 | β |
| Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels. | Boccone L et al. | β | 2013 | β |
| A Novel Deletion Mutation of SLC16A2 Encoding Monocarboxylate Transporter (MCT) 8 in a 26-year-old Japanese Patient with Allan-Herndon-Dudley Syndrome. | Yamamoto S et al. | β | 2013 | β |
| Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management. | Visser WE et al. | β | 2013 | β |
| Episodic movement disorders: from phenotype to genotype and back. | Brockmann K | β | 2013 | β |
| Function of thyroid hormone transporters in the central nervous system. | Schweizer U et al. | β | 2013 | β |
| Histidines in potential substrate recognition sites affect thyroid hormone transport by monocarboxylate transporter 8 (MCT8). | Braun D et al. | β | 2013 | β |
| Hypothyroidism and depression. | Dayan CM et al. | β | 2013 | β |
| Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation. | Visser WE et al. | β | 2013 | β |
| Inborn errors of brain myelin formation. | Boespflug-Tanguy O | β | 2013 | β |
| Inherited defects of thyroid hormone-cell-membrane transport: review of recent findings. | Fu J et al. | β | 2013 | β |
| Monocarboxylate transporter 8 modulates the viability and invasive capacity of human placental cells and fetoplacental growth in mice. | Vasilopoulou E et al. | β | 2013 | β |
| Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution. | Kersseboom S et al. | β | 2013 | β |
| Recent insights into the cell biology of thyroid angiofollicular units. | Colin IM et al. | β | 2013 | β |
| Relevance of different cellular models in determining the effects of mutations on SLC16A2/MCT8 thyroid hormone transporter function and genotype-phenotype correlation. | Capri Y et al. | β | 2013 | β |
| Tetrac can replace thyroid hormone during brain development in mouse mutants deficient in the thyroid hormone transporter mct8. | Horn S et al. | β | 2013 | β |
| The mitochondrial solute carrier SLC25A5 at Xq24 is a novel candidate gene for non-syndromic intellectual disability. | Vandewalle J et al. | β | 2013 | β |
| The pathophysiological consequences of thyroid hormone transporter deficiencies: Insights from mouse models. | Heuer H et al. | β | 2013 | β |
| The syndromes of reduced sensitivity to thyroid hormone. | Dumitrescu AM et al. | β | 2013 | β |
| [Diagnostic investigations for an unexplained developmental disability]. | Verloes A et al. | β | 2012 | β |
| Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency. | Verge CF et al. | β | 2012 | β |
| Finding the way into the brain without MCT8. | Visser WE et al. | β | 2012 | β |
| Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. | Finsterer J et al. | β | 2012 | β |
| Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain. | Mayerl S et al. | β | 2012 | β |
| Monocarboxylate transporter 10 functions as a thyroid hormone transporter in chondrocytes. | Abe S et al. | β | 2012 | β |
| The SLC16A family of monocarboxylate transporters (MCTs)--physiology and function in cellular metabolism, pH homeostasis, and fluid transport. | Adijanto J et al. | β | 2012 | β |
| Thyroid hormone transporters and deiodinases in the developing human hypothalamus. | Friesema EC et al. | β | 2012 | β |
| Understanding the hypothalamus-pituitary-thyroid axis in mct8 deficiency. | MΓΌller J et al. | β | 2012 | β |
| A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment. | Zung A et al. | β | 2011 | β |
| Aminoaciduria, but normal thyroid hormone levels and signalling, in mice lacking the amino acid and thyroid hormone transporter Slc7a8. | Braun D et al. | β | 2011 | β |
| Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells. | Braun D et al. | β | 2011 | β |
| Insights into molecular properties of the human monocarboxylate transporter 8 by combining functional with structural information. | Kleinau G et al. | β | 2011 | β |
| MCT8: from gene to disease and therapeutic approach. | Kersseboom S et al. | β | 2011 | β |
| Minireview: thyroid hormone transporters: the knowns and the unknowns. | Visser WE et al. | β | 2011 | β |
| Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy. | Wirth EK et al. | β | 2011 | β |
| Novel mutation in MCT8 gene in a Brazilian boy with thyroid hormone resistance and severe neurologic abnormalities. | Filho HC et al. | β | 2011 | β |
| Primary and secondary thyroid hormone transporters. | Kinne A et al. | β | 2011 | β |
| The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation. | Chan SY et al. | β | 2011 | β |
| The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary-thyroid axis. | Astapova I et al. | β | 2011 | β |
| Thyroid hormone and the neuroglia: both source and target. | MohΓ‘csik P et al. | β | 2011 | β |
| [Thyroid hormone resistance syndromes]. | Bernal J | β | 2011 | β |
| Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH. | Boccone L et al. | β | 2010 | β |
| Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. | Noor A et al. | β | 2010 | β |
| Elevated TSH levels in a mentally retarded boy. | Crushell E et al. | β | 2010 | β |
| Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. | Kinne A et al. | β | 2010 | β |
| Impact of monocarboxylate transporter-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice. | Trajkovic-Arsic M et al. | β | 2010 | β |
| The nature of the compensatory response to low thyroid hormone in the developing brain. | Sharlin DS et al. | β | 2010 | β |
| The role and potential sites of action of thyroid hormone in timing the onset of puberty in male primates. | Mann DR et al. | β | 2010 | β |
| Thyroid hormone action during brain development: more questions than answers. | Horn S et al. | β | 2010 | β |
| Thyroid hormone transporters in the brain. | Braun D et al. | β | 2010 | β |
| White matter abnormalities and dystonic motor disorder associated with mutations in the SLC16A2 gene. | Gika AD et al. | β | 2010 | β |
| A missense mutation, p.V132G, in the X-linked spermine synthase gene (SMS) causes Snyder-Robinson syndrome. | Becerra-Solano LE et al. | β | 2009 | β |
| A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport. | Di Cosmo C et al. | β | 2009 | β |
| Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutation. | Fuchs O et al. | β | 2009 | β |
| Endocrine-disrupting chemicals: an Endocrine Society scientific statement. | Diamanti-Kandarakis E et al. | β | 2009 | β |
| [Hypoglycemia and endocrine effects of adults' inborn errors of metabolism]. | Vantyghem MC et al. | β | 2009 | β |
| Minireview: Pathophysiological importance of thyroid hormone transporters. | Heuer H et al. | β | 2009 | β |
| Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. | Wirth EK et al. | β | 2009 | β |
| Novel insights into thyroid hormones from the study of common genetic variation. | Dayan CM et al. | β | 2009 | β |
| Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects. | Vaurs-BarriΓ¨re C et al. | β | 2009 | β |
| Prevalence and functional analysis of the S107P polymorphism (rs6647476) of the monocarboxylate transporter 8 (SLC16A2) gene in the male population of north-west Spain (Galicia). | Lago-LestΓ³n R et al. | β | 2009 | β |
| The blood-brain barrier thyroxine transporter organic anion-transporting polypeptide 1c1 displays atypical transport kinetics. | Westholm DE et al. | β | 2009 | β |
| 1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency. | Sijens PE et al. | β | 2008 | β |
| A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay. | Papadimitriou A et al. | β | 2008 | β |
| Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. | Gereben B et al. | β | 2008 | β |
| Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter. | Namba N et al. | β | 2008 | β |
| Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. | Friesema EC et al. | β | 2008 | β |
| Finding new etiologies of mental retardation and hypotonia: X marks the spot. | Rogers RC et al. | β | 2008 | β |
| Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8. | Jansen J et al. | β | 2008 | β |
| Hypothyroxinemia of prematurity: cause, diagnosis and management. | Ng SM | β | 2008 | β |
| MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression. | Frints SG et al. | β | 2008 | β |
| Multigenic control of thyroid hormone functions in the nervous system. | Nunez J et al. | β | 2008 | β |
| Neurodevelopmental and neurophysiological actions of thyroid hormone. | Williams GR | β | 2008 | β |
| Systemic onset juvenile idiopathic arthritis--its unusual presentation. | Ghosh JB et al. | β | 2008 | β |
| Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. | Schweizer U et al. | β | 2008 | β |
| Thyroid hormone and cerebellar development. | Anderson GW | β | 2008 | β |
| Thyroid hormone transport in and out of cells. | Visser WE et al. | β | 2008 | β |
| Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. | Trajkovic M et al. | β | 2007 | β |
| A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. | Risheg H et al. | β | 2007 | β |
| Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. | Jansen J et al. | β | 2007 | β |
| On commonness and rarity of thyroid hormone resistance: a discussion based on mechanisms of reduced sensitivity in peripheral tissues. | TjΓΈrve E et al. | β | 2007 | β |
| Placental transport of thyroid hormone. | James SR et al. | β | 2007 | β |
| Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. | Refetoff S et al. | β | 2007 | β |
| The importance of thyroid hormone transporters for brain development and function. | Heuer H | β | 2007 | β |
| The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. | Schwartz CE et al. | β | 2007 | β |
| Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. | Herzovich V et al. | β | 2007 | β |
| Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. | Maranduba CM et al. | β | 2006 | β |
| Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. | Friesema EC et al. | β | 2006 | β |
| Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. | Friez MJ et al. | β | 2006 | β |
| Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. | Beck-Peccoz P et al. | β | 2006 | β |
| The genetics of mental retardation. | Raymond FL et al. | β | 2006 | β |
| Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. | Dumitrescu AM et al. | β | 2006 | β |
| X linked mental retardation: a clinical guide. | Raymond FL | β | 2006 | β |
| X-linked mental retardation: many genes for a complex disorder. | Ropers HH | β | 2006 | β |
| Advances in X-linked mental retardation. | Stevenson RE | β | 2005 | β |
| X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype. | Holden KR et al. | β | 2005 | β |